ATE312617T1 - Verfahren zur herstellung von thylakoiden aus pflanzen, reine thylakoide und deren verwendung - Google Patents

Verfahren zur herstellung von thylakoiden aus pflanzen, reine thylakoide und deren verwendung

Info

Publication number: ATE312617T1
Authority: AT; Austria
Prior art keywords: thylacoids; extract; plants; pure; producing
Prior art date: 1999-12-30

Application number

AT00986929T

Other languages

English (en)

Inventor

Marc Purcell

Original Assignee

Purecell Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-30

Filing date

2000-12-29

Publication date

2005-12-15

2000-12-29 Application filed by Purecell Technologies Inc filed Critical Purecell Technologies Inc

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE312617T1 publication Critical patent/ATE312617T1/de

Links

238000004519 manufacturing process Methods 0.000 title 1
239000003642 reactive oxygen metabolite Substances 0.000 abstract 3
206010028980 Neoplasm Diseases 0.000 abstract 1
239000003963 antioxidant agent Substances 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
230000006806 disease prevention Effects 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
230000005855 radiation Effects 0.000 abstract 1
239000002516 radical scavenger Substances 0.000 abstract 1
210000002377 thylakoid Anatomy 0.000 abstract 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/34—Chemical or biological purification of waste gases
- B01D53/74—General processes for purification of waste gases; Apparatus or devices specially adapted therefor
- B01D53/84—Biological processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/20—Air quality improvement or preservation, e.g. vehicle emission control or emission reduction by using catalytic converters
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Botany (AREA)
Mycology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Environmental & Geological Engineering (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Birds (AREA)
Medical Informatics (AREA)
Oncology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Analytical Chemistry (AREA)
Molecular Biology (AREA)

AT00986929T 1999-12-30 2000-12-29 Verfahren zur herstellung von thylakoiden aus pflanzen, reine thylakoide und deren verwendung ATE312617T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002293852A CA2293852A1 (fr)	1999-12-30	1999-12-30	Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant
PCT/CA2000/001541 WO2001049305A2 (en)	1999-12-30	2000-12-29	Process for obtaining thylakoids from plants, pure thylakoids and use thereof

Publications (1)

Publication Number	Publication Date
ATE312617T1 true ATE312617T1 (de)	2005-12-15

Family

ID=4164997

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00986929T ATE312617T1 (de)	1999-12-30	2000-12-29	Verfahren zur herstellung von thylakoiden aus pflanzen, reine thylakoide und deren verwendung

Country Status (8)

Country	Link
US (2)	US7270839B2 (de)
EP (1)	EP1242104B1 (de)
JP (1)	JP4689129B2 (de)
AT (1)	ATE312617T1 (de)
AU (1)	AU2335501A (de)
CA (1)	CA2293852A1 (de)
DE (1)	DE60024870T2 (de)
WO (1)	WO2001049305A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2293852A1 (fr) *	1999-12-30	2001-06-30	Purecell Technologies Inc.	Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant
EP1401463B1 (de) *	2001-07-02	2005-09-21	Purecell Technologies Inc.	Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
WO2005027944A1 (en) *	2003-09-22	2005-03-31	Purecell Technologies Inc.	Oral compositions and route of administration for the delivery of a thylakoid extract
CA2609208C (en) *	2005-06-10	2016-10-18	Per-Ake Albertsson	Use of plant cell membrane for the treatment of obesity
WO2007109893A1 (en) *	2006-03-27	2007-10-04	Les Technologies Biofiltre Inc.	Plant extracts and uses thereof
US20080138393A1 (en) *	2006-12-11	2008-06-12	Access To Business Group International Llc	Water soluble extract of spinach for prevention and repair of DNA damage
US7824708B2 (en)	2006-12-11	2010-11-02	Access Business Group International Llc	Liposome containing cardiolipin for improvement of mitochondrial function
WO2008137092A2 (en)	2007-05-01	2008-11-13	Acidophil, Llc	Methods for the direct conversion of carbon dioxide into a hydrocarbon using a metabolically engineered photosynthetic microorganism
KR101025612B1 (ko) *	2008-11-10	2011-03-30	한국해양연구원	신규 화합물인 Ｒａｍａｌｉｎ 및 그 용도
US9637746B2 (en)	2008-12-15	2017-05-02	Greenlight Biosciences, Inc.	Methods for control of flux in metabolic pathways
CN105132387A (zh) *	2008-12-22	2015-12-09	绿光生物科学公司	用于制造化合物的组合物和方法
CA2699676C (en)	2010-04-12	2018-07-17	Purgenesis Technologies Inc.	The use of a photosynthetic cell extract in a cosmetic composition
EP2566953B1 (de)	2010-05-07	2019-01-02	Greenlight Biosciences, Inc.	Verfahren zur flusssteuerung bei stoffwechselwegen druch enzymumpositionierung
EP2611922A1 (de)	2010-08-31	2013-07-10	Greenlight Biosciences, Inc.	Verfahren zur flusssteuerung bei stoffwechselwegen durch proteasemanipulation
CN104093848A (zh)	2011-09-09	2014-10-08	绿光生物科学公司	碳青霉烯(carbapenem)的无细胞制备
HK1216547A1 (zh)	2012-12-21	2016-11-18	Greenlight Biosciences Inc.	用於將甲烷轉化成燃料、丙酮酸或異丁醇的無細胞系統
US9664696B1 (en) *	2013-05-30	2017-05-30	University Of Oregon	Compounds for determining the presence of hydrogen sulfide and methods of use
AU2014306074B2 (en)	2013-08-05	2018-08-30	Greenlight Biosciences, Inc.	Engineered proteins with a protease cleavage site
BR112017020690A2 (pt)	2015-03-30	2018-06-26	Greenlight Biosciences Inc	produção livre de células de ácido ribonucleico
JP2018536701A (ja) *	2015-11-03	2018-12-13	グループ・サンテ・デヴォニアン・インコーポレイテッド	炎症性腸疾患の治療用のチラコイド抽出組成物及び製剤
WO2017100915A1 (en) *	2015-12-14	2017-06-22	Groupe Santé Devonian Inc.	Extraction and process for active thylakoid membranes
CA3020312A1 (en)	2016-04-06	2017-10-12	Greenlight Biosciences, Inc.	Cell-free production of ribonucleic acid
US10725055B1 (en)	2016-04-15	2020-07-28	University Of Oregon	Compounds for carbonyl sulfide/carbon disulfide/hydrogen sulfide release and methods of making and using the same
US11187690B2 (en)	2016-06-03	2021-11-30	University Of Oregon	Synthetic receptors for hydrosulfide
US20200253870A1 (en) *	2016-10-05	2020-08-13	Council Of Scientific And Industrial Research	A ldv liposomal formulation of photo system-i for treatment of cancer
WO2018081903A1 (en) *	2016-11-04	2018-05-11	Groupe Santé Devonian Inc.	Composition for the prevention and/or treatment of cardiovascular diseases
EP3565892A4 (de)	2017-01-06	2020-10-07	Greenlight Biosciences, Inc.	Zellfreie herstellung von zuckern
KR102894284B1 (ko)	2017-10-11	2025-12-03	그린라이트 바이오사이언시스, 아이엔씨.	뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물
US11078157B1 (en)	2018-01-31	2021-08-03	University Of Oregon	Compound embodiments that release H2S by reaction with a reactive compound and methods of making and using the same
US11040942B1 (en)	2018-01-31	2021-06-22	University Of Oregon	Compound embodiments for hydrogen sulfide production and methods of making and using the same
US11021447B2 (en)	2018-05-14	2021-06-01	University Of Oregon	Fluorescent halogen bonding arylethynyl scaffolds for anion recognition
CN109125205A (zh) *	2018-08-16	2019-01-04	佛山市洵腾科技有限公司	一种抗衰老精华液及其制备方法
CN111929263B (zh) *	2020-08-11	2021-05-11	生态环境部卫星环境应用中心	臭氧廓线和二氧化硫柱浓度协同反演方法
CN113201067A (zh) *	2021-04-16	2021-08-03	北京大学	一种快速提纯细胞色素b6f的方法
WO2024239103A1 (en) *	2023-05-19	2024-11-28	Bio A3P Inc.	Topical cream for treating dermatological conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5200399A (en) *	1990-09-14	1993-04-06	Boyce Thompson Institute For Plant Research, Inc.	Method of protecting biological materials from destructive reactions in the dry state
JPH0987620A (ja)	1995-09-21	1997-03-31	Matsumi Iehara	子葉処理体及びその製造方法
SE9601677D0 (sv)	1996-05-02	1996-05-02	Scotia Lipidteknik Ab	New use
CA2293852A1 (fr) *	1999-12-30	2001-06-30	Purecell Technologies Inc.	Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant

1999
- 1999-12-30 CA CA002293852A patent/CA2293852A1/fr not_active Abandoned
2000
- 2000-12-29 EP EP00986929A patent/EP1242104B1/de not_active Expired - Lifetime
- 2000-12-29 AT AT00986929T patent/ATE312617T1/de not_active IP Right Cessation
- 2000-12-29 US US10/169,931 patent/US7270839B2/en not_active Expired - Lifetime
- 2000-12-29 DE DE60024870T patent/DE60024870T2/de not_active Expired - Lifetime
- 2000-12-29 JP JP2001549673A patent/JP4689129B2/ja not_active Expired - Lifetime
- 2000-12-29 AU AU23355/01A patent/AU2335501A/en not_active Abandoned
- 2000-12-29 WO PCT/CA2000/001541 patent/WO2001049305A2/en not_active Ceased
2007
- 2007-04-12 US US11/734,449 patent/US8632824B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4689129B2 (ja)	2011-05-25
EP1242104B1 (de)	2005-12-14
WO2001049305A3 (en)	2001-11-29
US7270839B2 (en)	2007-09-18
DE60024870T2 (de)	2006-08-17
JP2003519191A (ja)	2003-06-17
US20030175374A1 (en)	2003-09-18
AU2335501A (en)	2001-07-16
EP1242104A2 (de)	2002-09-25
US8632824B2 (en)	2014-01-21
DE60024870D1 (de)	2006-01-19
WO2001049305A2 (en)	2001-07-12
CA2293852A1 (fr)	2001-06-30
US20070202198A1 (en)	2007-08-30

Legal Events

Date	Code	Title	Description
2006-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE312617T1 (de)	2005-12-15	Verfahren zur herstellung von thylakoiden aus pflanzen, reine thylakoide und deren verwendung
EP4685213A3 (de)	2026-04-01	Reinigung von erneuerbaren organischen recycling-stoffen
WO2004039959A3 (en)	2005-05-12	Improved ethanol production process
DE60233075D1 (de)	2009-09-03	Mehrstufiges bestrahlungsverfahren zur herstellung eines klebstoffs auf acrylbasis
WO2005020932A3 (en)	2005-07-28	Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
TR199900610T2 (xx)	1999-06-21	Polifenol i�eren terkiplerin �retim y�ntemi.
WO2002098210A3 (en)	2004-04-15	Chromosome doubling method
JO2347B1 (en)	2006-06-28	Process and desalination device using diffusion
MY160529A (en)	2017-03-15	Method for treating diamond material and product obtained
EP1338565A3 (de)	2005-01-05	Générateur de radicaux libres et procédé de traitement d'eau
BRPI0308385A8 (pt)	2018-02-14	processo para purificar uma composição compreendendo ácido (met)acrílico, aparelho para produzir ácido (met)acrílico e aparelho para polimerizar ácido (met)acrílico
EA201101425A1 (ru)	2012-05-30	Способ уменьшения повреждения растений солнечными ожогами
DE60230327D1 (de)	2009-01-22	Polymorphe von clopidogrel-hydrogensulfat
WO2002063091A3 (de)	2003-11-27	Verfahren zur uv-schutzausrüstung von textilem material
DE60319398D1 (de)	2008-04-10	Verfahren zur herstellung einer pureezusammensetzung enthaltend eine stabilisierte fruchtmarkzusammensetzung
NO20054614L (no)	2005-10-07	Fremgangsmate til fremstilling av 68Ga
TR200103634T2 (tr)	2002-04-22	Bitkilerde flavonoidlerin ve fenolik maddelerin miktarını arttırma yöntemi.
ATE216252T1 (de)	2002-05-15	Myrteextrakt, verfahren zur herstellung und verwendung
DE60008798D1 (de)	2004-04-08	Extrakt von undifferenzierten zellen einer pflanze der gattung leontopodium und ihn enthaltende zusammensetzungen
WO2005065323A3 (en)	2006-10-05	Light-activated biocidal polyelectrolytes
EA200500775A1 (ru)	2005-12-29	Эфиры карбаминовой кислоты, обладающие антихолинергическим действием
AR011900A1 (es)	2000-09-13	Un metodo para regular el nivel en un tanque separador
DE602004002215D1 (de)	2006-10-12	Aus trigonella foenum graecum-extrakten hergestellter elicitor für die behandlung von pflanzenpathogenen, seine verwendung sowie verfahren zu seiner herstellung
AU2001263318A1 (en)	2001-11-26	Apparatus and process for in situ manufacture of essence from living, uncut plants
DK1331939T3 (da)	2007-01-15	Murraya koenigii-ekstrakter til behandling af astma